Interestingly, both studied inhibitors, i.e., DMAT and rac-6, are able to induce autophagy in the BCR-ABL-positive chronic myeloid leukemia (CML) cell line. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.